Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence

References

• KanisJADiagnosis of osteoporosis and assessment of fracture riskLancet200235993211929193612057569
   PubMed Web of Science ®Google Scholar
• ZhangZQHoSCChenZQZhangCXChenYMReference values of bone mineral density and prevalence of osteoporosis in Chinese adultsOsteoporos Int201425249750723800746
   PubMed Web of Science ®Google Scholar
• BliucDNguyenNDMilchVENguyenTVEismanJACenterJRMortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and womenJAMA2009301551352119190316
   PubMed Web of Science ®Google Scholar
• SiLWinzenbergTMde GraaffBPalmerAJA systematic review and meta-analysis of utility-based quality of life for osteoporosis-related conditionsOsteoporos Int201425811123797847
   PubMed Web of Science ®Google Scholar
• QuBMaYYanMThe economic burden of fracture patients with osteoporosis in western ChinaOsteoporos Int20142571853186024691649
   PubMed Web of Science ®Google Scholar
• SiLWinzenbergTMChenMJiangQPalmerAJResidual lifetime and 10 year absolute risks of osteoporotic fractures in Chinese men and womenCurr Med Res Opin20153161149115625851177
   PubMed Web of Science ®Google Scholar
• SiLWinzenbergTMJiangQChenMPalmerAJProjection of osteoporosis-related fractures and costs in China: 2010–2050Osteoporos Int20152671929193725761729
   PubMed Web of Science ®Google Scholar
• CranneyATugwellPZytarukNMeta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosisEndocr Rev200223452452812202467
   PubMed Web of Science ®Google Scholar
• BorgstromFJohnellOKanisJAOdenASykesDJonssonBCost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE studyPharmacoeconomics200422171153116515612833
   PubMed Web of Science ®Google Scholar
• MithalAEbelingPKyerCSAsia-Pacific regional audit: epidemiology, costs and burden of osteoporosis in 2013Nyon, SwitzerlandInternational Osteoporosis Foundation2013
   Google Scholar
• Ministry of Labor and Social Security of the People’s Republic of ChinaNotice about publishing BHIS Formulary2004 Chinese
   Google Scholar
• Ministry of Labor and Social Security of the People’s Republic of ChinaNotice about publishing BHIS Formulary2013 Chinese
   Google Scholar
• ClementFMHarrisALiJYongKLeeKMMannsBJUsing effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and CanadaJAMA2009302131437144319809025
   PubMed Web of Science ®Google Scholar
• SiLWinzenbergTMJiangQPalmerAJScreening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness modelOsteoporos Int20152651477148925567776
   PubMed Web of Science ®Google Scholar
• WangJWangYLiuWDWangFYinZSHip fractures in Hefei, China: the Hefei osteoporosis projectJ Bone Miner Metab201432220621423784553
   PubMed Web of Science ®Google Scholar
• BowCHCheungECheungCLEthnic difference of clinical vertebral fracture riskOsteoporos Int201223387988521461720
   PubMed Web of Science ®Google Scholar
• LofthusCMFrihagenFMeyerHENordslettenLMelhuusKFalchJAEpidemiology of distal forearm fractures in Oslo, NorwayOsteoporos Int200819678178617985071
   PubMed Web of Science ®Google Scholar
• MeltonLJ3rdThamerMRayNFFractures attributable to osteoporosis: report from the National Osteoporosis FoundationJ Bone Miner Res199712116239240721
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of ChinaChina Public Health Statistical YearbookBeijing, ChinaPeking Union Medical College Publishing House2012
   Google Scholar
• China Center for Health Economic ResearchChina Guidelines for Pharmacoeconomic EvaluationsBeijing, ChinaChina Center for Health Economic Research2011
   Google Scholar
• ChungMLeeJTerasawaTLauJTrikalinosTAVitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task ForceAnn Intern Med20111551282783822184690
   PubMed Web of Science ®Google Scholar
• CranneyATugwellPZytarukNMeta-analyses of therapies for post-menopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosisEndocr Rev200223454055112202469
   PubMed Web of Science ®Google Scholar
• WellsGACranneyAPetersonJAlendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenCochrane Database Syst Rev20081Cd00115518253985
   PubMed Web of Science ®Google Scholar
• CCEMG EPPICCEMG – EPPI-Centre Cost Converter2013 Available from: http://eppi.ioe.ac.uk/costconversion/default.aspxAccessed April 24, 2013
   Google Scholar
• Medicine Price Platform, Jiangsu Province Available from: http://yy.jspn.net/Accessed July 4, 2014
   Google Scholar
• GrayAMClarkePMWolstenholmeJLWordsworthSApplied Methods of Cost-Effectiveness Analysis in HealthcareOxford, UKOxford University Press20108889
   Google Scholar
• TolleyKWhat are Health UtilitiesLondon, UKHayward Medical Communications200918
   Google Scholar
• SunSChenJJohannessonMPopulation health status in China: EQ-5D results, by age, sex and socioeconomic status, from the National Health Services Survey 2008Qual Life Res201120330932021042861
   PubMed Web of Science ®Google Scholar
• ChengTTYuSFHsuCYChenSHSuBYYangTSDifferences in adherence to osteoporosis regimens: a 2-year analysis of a population treated under specific guidelinesClin Ther20133571005101523831360
   PubMed Web of Science ®Google Scholar
• GiustiABaroneARazzanoMPersistence with calcium and vitamin D in elderly patients after hip fractureJ Bone Miner Metab20092719510019018453
   PubMed Web of Science ®Google Scholar
• JacksonRDLaCroixAZGassMCalcium plus vitamin D supplementation and the risk of fracturesN Engl J Med2006354766968316481635
   PubMed Web of Science ®Google Scholar
• HiligsmannMBoonenARabendaVReginsterJYThe importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosisExpert Rev Pharmacoecon Outcomes Res201212215916622458617
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• SirisESSelbyPLSaagKGBorgstromFHeringsRMSilvermanSLImpact of osteoporosis treatment adherence on fracture rates in North America and EuropeAm J Med20091222 SupplS3S1319187810
   PubMed Web of Science ®Google Scholar
• NayakSRobertsMSGreenspanSLCost-effectiveness of different screening strategies for osteoporosis in postmenopausal womenAnn Intern Med20111551175176122147714
   PubMed Web of Science ®Google Scholar
• HuybrechtsKFIshakKJCaroJJAssessment of compliance with osteoporosis treatment and its consequences in a managed care populationBone200638692292816330270
   PubMed Web of Science ®Google Scholar
• RabendaVMertensRFabriVAdherence to bisphosphonates therapy and hip fracture risk in osteoporotic womenOsteoporos Int200819681181817999022
   PubMed Web of Science ®Google Scholar
• BriggsAHWeinsteinMCFenwickEAKarnonJSculpherMJPaltielADModel parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force – 6Value Health201215683584222999133
   PubMed Web of Science ®Google Scholar
• HusereauDDrummondMPetrouSConsolidated health economic evaluation reporting standards (CHEERS) – explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task forceValue Health201316223125023538175
   PubMed Web of Science ®Google Scholar
• SiLWinzenbergTMPalmerAJA systematic review of models used in cost-effectiveness analyses of preventing osteoporotic fracturesOsteoporos Int2014251516024154803
   PubMed Web of Science ®Google Scholar
• HiligsmannMRabendaVBruyereOReginsterJYThe clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patientsHealth Policy201096217017720153543
   PubMed Web of Science ®Google Scholar
• CobdenDSNiessenLWRuttenFFHRedekopWKModeling the economic impact of medication adherence in type 2 diabetes: a theoretical approachPatient Prefer Adherence2010428329020859455
   PubMed Web of Science ®Google Scholar
• BliucDAlarkawiDNguyenTVEismanJACenterJRRisk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology StudyJ Bone Miner Res201530463764625359586
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEMoscaLCollinsPEffects of raloxifene on cardiovascular events and breast cancer in postmenopausal womenN Engl J Med2006355212513716837676
   PubMed Web of Science ®Google Scholar
• CummingsSRMeltonLJEpidemiology and outcomes of osteoporotic fracturesLancet200235993191761176712049882
   PubMed Web of Science ®Google Scholar
• CooleyHJonesGA population-based study of fracture incidence in southern Tasmania: lifetime fracture risk and evidence for geographic variations within the same countryOsteoporos Int200112212413011303712
   PubMed Web of Science ®Google Scholar